| Literature DB >> 26039453 |
Luz D Orozco1, Marco Morselli1, Liudmilla Rubbi1, Weilong Guo2, James Go3, Huwenbo Shi4, David Lopez1, Nicholas A Furlotte5, Brian J Bennett6, Charles R Farber7, Anatole Ghazalpour8, Michael Q Zhang2, Renata Bahous9, Rima Rozen9, Aldons J Lusis8, Matteo Pellegrini10.
Abstract
Heritable epigenetic factors can contribute to complex disease etiology. Here we examine the contribution of DNA methylation to complex traits that are precursors to heart disease, diabetes, and osteoporosis. We profiled DNA methylation in the liver using bisulfite sequencing in 90 mouse inbred strains, genome-wide expression levels, proteomics, metabolomics, and 68 clinical traits and performed epigenome-wide association studies (EWAS). We found associations with numerous clinical traits including bone density, insulin resistance, expression, and protein and metabolite levels. A large proportion of associations were unique to EWAS and were not identified using GWAS. Methylation levels were regulated by genetics largely in cis, but we also found evidence of trans regulation, and we demonstrate that genetic variation in the methionine synthase reductase gene Mtrr affects methylation of hundreds of CpGs throughout the genome. Our results indicate that natural variation in methylation levels contributes to the etiology of complex clinical traits.Entities:
Mesh:
Year: 2015 PMID: 26039453 PMCID: PMC4454894 DOI: 10.1016/j.cmet.2015.04.025
Source DB: PubMed Journal: Cell Metab ISSN: 1550-4131 Impact factor: 27.287